Nordic AML Insights – July-August Update

Explore the latest contributions from the Nordics to acute myeloid leukemia research — from AI-driven predictions of personalized drug combinations and novel MRD biomarkers to population-based survival data and therapeutic insights into iron metabolism. These studies showcase how machine learning, genomic profiling, and real-world evidence are driving innovation in AML treatment across the region.
Don’t miss these exciting developments!